Impact of early cyclosporin average blood concentration on early kidney transplant failure

Transplant International

Volumn 11, Issue 1, 1998, Pages 46-52

  Senel, M Ferda ^a   Van Buren, Charles T ^a   Welsh, Maria ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cyclosporin, pharmacokinetics, kidney transplantation; Kidney transplantation, cyclosporin, pharmacokinetics

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISOLONE;

ADULT; AGED; ARTICLE; DRUG BLOOD LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY;

ADULT; COHORT STUDIES; CYCLOSPORINE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES;

EID: 0031891156     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050101     Document Type: Article

References (16)

1. Calne RY, White DJ, Thiru S, Evans DB, McMaster R Dunn DC, Craddock GN, Pentlow BD, Rolles K (1978) Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet II: 1323
2. Canadian Multicenter Transplant Study Group (1983) A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 309: 809-815
3. Frey FJ, Horber FF, Frey M (1988) Trough levels and concentration time curves of cyclosporine in patients undergoing renal transplantation. Clin Pharmacol Ther 43: 55-62
4. Grevel J, Kahan BD (1990) Area under the curve monitoring of cyclosporine therapy: the early post-transplant period. Ther Drug Monit 13: 89-95
5. Grevel J, Kahan BD (1991) Abbreviated kinetic profiles in area under the curve monitoring of cyclosporine therapy. Clin Chem 37: 1905-1908
6. Kahan BD (1988) Optimization of cyclosporine therapy. Transplant Proc 25: 5-9
7. Kahan BD, Welsh M, Knight R, Katz S, Lewis R, Grevel J, Van Buren CT (1992) Pharmacokinetic strategies for cyclosporine therapy in organ transplantation. J Autoimmun 5: 333-341
8. Kahan BD, Welsh M, Rutzky L, Lewis R, Knight R, Katz S, Napoli K, Grevel J, Van Buren CT (1992) The ability of pretransplant test-dose pharmacokinetic profiles to reduce early adverse events after renal transplantation. Transplantation 53: 345-351
9. Kasiske BL, Heim-Duthoy K, Rao KV, Awni WM (1988) The relation between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients. Transplantation 46: 716-722
10. Lindholm A (1991) Therapeutic monitoring of cyclosporine: an update. Eur J Clin Pharmacol 41: 273-283
11. Lindholm A, Kahan BD (1993) Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54: 205-218
12. Moyer TP, Post GR, Sterioff S, Anderson CF (1988) Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood. Mayo Clin Proc 63: 241-247
13. Napoli KL, Kahan BD (1991) Considerations for monitoring cyclosporine in transplant recipients. Clin Lab Med 11: 671-691
14. Ptachcinski RJ, Venkataramanan R, Rosenthal JT, Burckart GJ, Taylor RJ, Hakala T (1985) Cyclosporine kinetics in renal transplantation. Clin Pharmacol Ther 38: 296-300
15. Sommer BG, Sing DE, Henry ML, Ferguson RM, Orozs CG (1988) Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation. Transplantation 45: 86-90
16. Takahara S, Kokado Y, Kameoka H, Moutabarrik A, Jiang H, Ishibashi M, Okuyama A, Nishi Y, Chiba N, Sonoda T (1994) Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK506-treated kidney transplant recipients. Transplant Proc 26: 2802-2806